Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sunshine Biopharma | 1.60 Mn | -12.15 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.32% |
| Mar 31, 2026 | 24.07% |
| Sep 30, 2025 | 98.12% |
| Mar 31, 2025 | 55.60% |
| Dec 31, 2024 | -379.36% |
| Sep 30, 2024 | -0.18% |
| Jun 30, 2024 | -84.01% |
| Mar 31, 2024 | 20.18% |
| Dec 31, 2023 | -168.27% |
| Sep 30, 2023 | -32.46% |
| Jun 30, 2023 | -19.31% |
| Mar 31, 2023 | -97.10% |
| Dec 31, 2022 | 455.81% |
| Sep 30, 2022 | -4,805.47% |
| Mar 31, 2022 | -211.92% |
| Dec 31, 2021 | 34.96% |
| Sep 30, 2021 | 9.00% |
| Jun 30, 2021 | 56.54% |
| Mar 31, 2021 | -126.48% |
| Dec 31, 2020 | 38.62% |